Cargando...
Inflammatory bowel disease surgery in the biologic era
Anti-tumour necrosis factor (TNF)-α therapy has revolutionized inflammatory bowel disease (IBD) treatment. Infliximab and adalimumab either as monotherapy or in combination with an immunomodulator are able to induce clinical and biological remission in patients with moderate and severe Crohn’s disea...
Gardado en:
| Publicado en: | World J Gastrointest Surg |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872064/ https://ncbi.nlm.nih.gov/pubmed/27231514 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v8.i5.363 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|